Annual report
4368.TEDINET S100OHQ4
Period2021-04-01 → 2022-03-31
Filed2022-06-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥55.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥42.2bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥41.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥42.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥40.2bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥15.0bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥9.6bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥15.5bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥9.7bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥9.0bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥9.9bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.4bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥15.7bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥9.7bn | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥10.9bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.8bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥7.0bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.9bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.6bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥10.9bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥6.8bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥92.0bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥76.0bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥69.2bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥64.5bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥64.2bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥16.7bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥9.9bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥75.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥66.2bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥60.3bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥55.3bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥50.1bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥24.2bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥25.6bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥23.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥24.8bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥16.1bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.2bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥18.9bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥10.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥12.8bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥11.9bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥8.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.8bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥9.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.6bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥15.4bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥8.0bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥2.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.6bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.6bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.6bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.7bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥308.08 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥191.75 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥197.56 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥193.81 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥185.67 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,136.65 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,863.74 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,698.11 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,558.77 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,412.21 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 81.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.0% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.1% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.9% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.1% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 15.4% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.8% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.1% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.8% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 805 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 794 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 781 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 761 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 755 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥46.2bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥35.4bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥34.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥34.5bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥33.3bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥12.3bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥7.8bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥14.0bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥9.2bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥8.1bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥9.9bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥9.8bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥14.2bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥9.2bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥10.2bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥6.8bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥6.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥6.5bn | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥84.0bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥69.7bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥63.5bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥58.6bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥57.9bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥16.6bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥9.4bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥67.4bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥60.2bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥54.9bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥49.9bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥44.2bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥20.0bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥21.9bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥287.48 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥190.88 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥189.76 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥207.55 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥181.87 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥55 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥48 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥46 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥46 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,913.17 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,696.88 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,547.58 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,405.37 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,244.93 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 80.3% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.5% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.5% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.2% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.3% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 15.9% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.8% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.7% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.5% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 35,511,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,511,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,511,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,511,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,511,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 491 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 481 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 467 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 445 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 437 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 52
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥303m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥74m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥23.9bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥1.5bn |
| Electronic Materials And Functional Chemicals Business Unitreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥10.0bn |
| Electronic Materials And Functional Chemicals Business Unitreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Electronic Materials And Functional Chemicals Business Unitreportable segment | employees | at 2022-03-31 | 278 pure |
| Electronic Materials And Functional Chemicals Business Unitreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥24.3bn |
| Electronic Materials And Functional Chemicals Business Unitreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥24.3bn |
| Electronic Materials And Functional Chemicals Business Unitreportable segment | segment assets | at 2022-03-31 | ¥34.2bn |
| Electronic Materials And Functional Chemicals Business Unitreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥11.6bn |
| Life Science Business Unitreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥2.2bn |
| Life Science Business Unitreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥1.5bn |
| Life Science Business Unitreportable segment | employees | at 2022-03-31 | 486 pure |
| Life Science Business Unitreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥31.4bn |
| Life Science Business Unitreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥31.4bn |
| Life Science Business Unitreportable segment | segment assets | at 2022-03-31 | ¥33.9bn |
| Life Science Business Unitreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥4.9bn |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥12.2bn |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥4.4bn |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥55.8bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥55.8bn |
| —segment total | segment assets | at 2022-03-31 | ¥68.2bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥16.6bn |
| Reconciling Itemsreconciling | capex | 2020-04-01 → 2021-03-31 | ¥366m |
| Reconciling Itemsreconciling | depreciation | 2020-04-01 → 2021-03-31 | ¥29m |
| Reconciling Itemsreconciling | revenue | 2020-04-01 → 2021-03-31 | −¥222,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2020-04-01 → 2021-03-31 | −¥222,000 |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥25.9bn |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2021-03-31 | −¥1.3bn |
| Electronic Materials And Functional Chemicals Business Unitreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥610m |
| Electronic Materials And Functional Chemicals Business Unitreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥3.4bn |
| Electronic Materials And Functional Chemicals Business Unitreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥18.8bn |
| Electronic Materials And Functional Chemicals Business Unitreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥18.8bn |
| Electronic Materials And Functional Chemicals Business Unitreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥222,000 |
| Electronic Materials And Functional Chemicals Business Unitreportable segment | segment assets | at 2021-03-31 | ¥22.6bn |
| Electronic Materials And Functional Chemicals Business Unitreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥7.6bn |
| Life Science Business Unitreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥915m |
| Life Science Business Unitreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥1.6bn |
| Life Science Business Unitreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥23.4bn |
| Life Science Business Unitreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥23.4bn |
| Life Science Business Unitreportable segment | segment assets | at 2021-03-31 | ¥27.5bn |
| Life Science Business Unitreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥3.3bn |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥1.5bn |
| —segment total | depreciation | 2020-04-01 → 2021-03-31 | ¥5.0bn |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥42.2bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥42.2bn |
| —segment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥222,000 |
| —segment total | segment assets | at 2021-03-31 | ¥50.1bn |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | ¥11.0bn |
| Electronic Materials And Functional Chemicals Business Unitreportable segment | employees | at 2022-03-31 | 265 pure |
| Life Science Business Unitreportable segment | employees | at 2022-03-31 | 185 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,657
| Item | Context | Value | Unit |
|---|---|---|---|
| Deferred tax liabilities | Prior1YearInstant | 178135000 | JPY |
| Deferred tax liabilities | CurrentYearInstant | 187187000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 1534544000 | JPY |
| Net defined benefit liability | CurrentYearInstant | 1555891000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 8289000 | JPY |
| Asset retirement obligations ncl | CurrentYearInstant | 8289000 | JPY |
| Long term accounts payable facilities | Prior1YearInstant | 196952000 | JPY |
| Long term accounts payable facilities | CurrentYearInstant | 182180000 | JPY |
| Other ncl | Prior1YearInstant | 108657000 | JPY |
| Other ncl | CurrentYearInstant | 105202000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 2026579000 | JPY |
| Noncurrent liabilities | CurrentYearInstant | 2038751000 | JPY |
| Liabilities | Prior1YearInstant | 9862838000 | JPY |
| Liabilities | CurrentYearInstant | 16706154000 | JPY |
| Capital stock | Prior1YearInstant | 4334047000 | JPY |
| Capital stock | CurrentYearInstant | 4334047000 | JPY |
| Capital surplus | Prior1YearInstant | 4820722000 | JPY |
| Capital surplus | CurrentYearInstant | 4820722000 | JPY |
| Retained earnings | Prior1YearInstant | 55121274000 | JPY |
| Retained earnings | CurrentYearInstant | 64183183000 | JPY |
| Treasury stock | Prior1YearInstant | -4771000 | JPY |
| Treasury stock | CurrentYearInstant | -1112561000 | JPY |
| Shareholders equity | Prior1YearInstant | 64271272000 | JPY |
| Shareholders equity | CurrentYearInstant | 72225391000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 475600000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | 421137000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | 16513000 | JPY |
| Deferred gains or losses on hedges | CurrentYearInstant | 25107000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 1406202000 | JPY |
| Foreign currency translation adjustment | CurrentYearInstant | 2631711000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 1898315000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | 3077957000 | JPY |
| Net assets | Prior1YearInstant | 66169588000 | JPY |
| Net assets | CurrentYearInstant | 75303348000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 76032427000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 92009502000 | JPY |
| Net sales | Prior1YearDuration | 42209380000 | JPY |
| Net sales | CurrentYearDuration | 55760482000 | JPY |
| Cost of sales | Prior1YearDuration | 25861584000 | JPY |
| Cost of sales | CurrentYearDuration | 32679133000 | JPY |
| Gross profit | Prior1YearDuration | 16347796000 | JPY |
| Gross profit | CurrentYearDuration | 23081348000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration | 6715583000 | JPY |
| Selling general and administrative expenses | CurrentYearDuration | 8046587000 | JPY |
| Operating income | Prior1YearDuration | 9632212000 | JPY |
| Operating income | CurrentYearDuration | 15034761000 | JPY |
| Interest income noi | Prior1YearDuration | 20391000 | JPY |
| Interest income noi | CurrentYearDuration | 16913000 | JPY |
| Dividends income noi | Prior1YearDuration | 25412000 | JPY |
| Dividends income noi | CurrentYearDuration | 30855000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |